Logo mit Claim
  • Datenschutz
  • Nutzungsbedingungen
  • Kontakt
  • Impressum

Sanofi Genzyme und Regeneron haben sich verpflichtet, die Erforschung neuer Medikamente für Patienten mit Erkrankungen mit Typ-2-Inflammation voranzutreiben.

© 2021 Sanofi-Aventis Deutschland GmbH. Alle Rechte vorbehalten. | MAT-DE-2000497-5.0-09/2021

Leaving to HCP site

This site is intended for U.S. Healthcare Professionals only.

Do you wish to continue?

You are leaving a Sanofi US website

You will be taken out of EMS site

You are about to leave sanofi site for U.S.

Sanofi US does not review the information contained on this website and/or database for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions set by the website and/or database producer.

This site might not comply with the regulatory requirements of US

You are about to move to an Unbranded site

You are moving to an Unbranded site